While TNF-alpha inhibition must be weighed against immunosuppression risk, there is no evidence of TNF blockade increasing the risk of infection in the acute phase, and our case supports the potential role for prolonged TNF-alpha inhibition given persistent inflammation in ICI-induced cutaneous irAEs. The gene discussed is TNF; the disease is infection.